ArticleScience advances2023

Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance.

Sara G Danielli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.